MNOV Q3 2022 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$71M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.07

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$158,298

Balance Sheet

Total Assets

$78M

Total Liabilities

$5M

Stockholders' Equity

$73M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$37,500	-100.0%
Gross Profit	$0	$37,500	-100.0%
Operating Income	-$4M	-$4M	-8.2%
Net Income	-$4M	-$4M	-2.0%